Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synthase inhibition

Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synthase inhibition

US Patent 10292984 · Granted May 21, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2022
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2022
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2022
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2022
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2022
[6R]—MTHF—an efficient folate alternative in 5-fluorouracil based chemotherapy2021
[6R]—MTHF—an efficient folate alternative in 5-fluorouracil based chemotherapy2021
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2020
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2020
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2020
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2020
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2020